google-site-verification: googlec7193c3de77668c9.html

Why CAR T therapy works for some patients but fails for others may be getting clearer

[
Chimeric antigen receptor (CAR) T-cell therapy is one of oncology’s most powerful ideas: Harvest a cancer patient’s own immune cells, genetically engineer them to recognize tumor cells, multiply them in a laboratory and reinject them as a living drug. For some patients, the treatment produces extraordinary, durable remissions. For many others, however, it produces nothing, but new research sheds light on the reason.


Source link

Advertisements
Views: 3

See also  Tracking sleep with an app? Why insomnia sufferers may feel worse, not better

Check Also

A ban won’t stop abortion pill access, telehealth providers say

[ Two developments often get lost in the public’s perception of the abortion wars. One …

Crash victims are 70% less likely to be transferred between hospitals in no-fault states

[ Patients with severe injuries from car crashes are about 70% less likely to be …

Leveraging AI can reduce time and resources in how physicians approach sepsis care

[ Credit: Thirdman from Pexels In a new clinical study from the University of California …

Leave a Reply

Available for Amazon Prime
heavy equipment transport brevard fl.